SFRP2 and gastric cancer: Meanwhile, sFRP2 is downregulated by epigenetic promoter hypermethylation in gastric cancer [18], colorectal cancer [19], melanoma [20], and oral squamous cell carcinoma [21], suggesting that sFRP2 could be regarded as a tumor suppressor.